Results 241 to 250 of about 13,357,463 (271)

Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity

Rheumatology International, 2015
The aim of this study was to investigate the presence of subclinical atherosclerosis among psoriatic arthritis (PsA) patients without any cardiovascular disease (CVD) or traditional cardiovascular risk factors through measurement of endothelial function and carotid intima-media thickness (IMT) and correlated with disease-related risk factors.
Kir, HALE, YILMAZER, Baris, Unlu, BERRİN, ŞAHİN, TAYFUN, ÇEFLE, AYŞE   +4 more
openaire   +3 more sources

Altered activity of plasma hemopexin in patients with minimal change disease in relapse

Pediatric Nephrology, 2005
Since an active isoform of plasma hemopexin (Hx) has been proposed to be a potential effector molecule in minimal change disease (MCD), we tested plasma and urine samples from subjects with MCD in relapse (n = 18) or in remission (n = 23) (after treatment with prednisolone) for presence or activity of Hx.
Bakker, Winston W., van Dael, Catharina M.L., Pierik, Leonie J.W.M., van Wijk, Joanna A.E., Nauta, Jeroen, Borghuis, Theo, Kapojos, Jola J.   +6 more
openaire   +4 more sources

Low disease activity state in rheumatoid arthritis: concepts and derivation of minimal disease activity.

Clinical and experimental rheumatology, 2007
With recent advances in therapy, the proportion of patients achieving a satisfactory state of minimal disease activity (MDA) is becoming a more important measure with which to compare different treatment strategies. MDA is between high disease activity and remission and anyone in remission will also be in MDA.
G, Wells, M, Boers, P, Tugwell
openaire   +1 more source

Treating Psoriatic Arthritis to Target: Defining the Psoriatic Arthritis Disease Activity Score That Reflects a State of Minimal Disease Activity

The Journal of Rheumatology, 2019
Objective.The Psoriatic Arthritis Disease Activity Score (PASDAS) is a composite disease activity measure (range 0–10) for psoriatic arthritis (PsA). We aimed to validate a cutoff value of PASDAS that defines minimal disease activity (MDA) state, as well as to validate previously defined PASDAS cutoffs for low and high disease activity.Methods.Patients
Anthony V. Perruccio, Matthew Got, Suzanne Li, Yang Ye, Dafna D. Gladman, Vinod Chandran   +5 more
openaire   +2 more sources

Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment

Annals of the Rheumatic Diseases, 2010
To create minimal disease activity (MDA) criteria for psoriatic arthritis (PsA). With recent therapeutic advances, this is now a goal for treatment and may represent a measure to compare therapies. It defines a satisfactory state of disease activity rather than a change, and encompasses all aspects of the disease.40 patient profiles were sampled from ...
Coates, L.C., Fransen, J., Helliwell, P.S.   +2 more
openaire   +3 more sources

Minimal Disease Activity and Anti–Tumor Necrosis Factor Therapy in Psoriatic Arthritis

Arthritis Care & Research, 2015
ObjectiveA state of minimal disease activity (MDA) was defined and validated as target for treatment in psoriatic arthritis (PsA). We aimed to identify disease characteristics, outcome, and predictors of MDA in patients treated with tumor necrosis factor α (TNFα) blockers.MethodsPatients fulfilling the Classification of Psoriatic Arthritis criteria ...
Amir, Haddad, Arane, Thavaneswaran, Ioana, Ruiz-Arruza, Fawnda, Pellett, Vinod, Chandran, Richard J, Cook, Dafna D, Gladman   +6 more
openaire   +2 more sources

Epigenetics of Pulmonary Diseases

Medical Epigenetics, 2021
Narasaiah Kolliputi
exaly  

Achieving minimal disease activity in psoriatic arthritis in therapeutic practice

Practical medicine
The purpose — to identify and analyze the minimal disease activity (MDA) domains in psoriatic arthritis (PsA) most difficult to achieve in clinical practice. Material and methods. The research included 114 adult patients with PsA who were admitted to the Republican Clinical Diagnostic Center and assessed for compliance with the MDA criteria. Results.
openaire   +1 more source

Soluble CD93 Contributes to Podocyte Activation in Minimal Change Disease

Journal of the American Society of Nephrology, 2023
Colin D. Bauer, Federica Piani, Miguel A. Lanaspa, Ana Andres-Hernando, Petter Bjornstad, Kazunari Kaneko, Joshua M. Thurman, Richard J. Johnson, Gabriel M. Cara-Fuentes   +8 more
openaire   +1 more source

The Potential Value of Minimal Disease Activity in Atopic Dermatitis

Journal of Cutaneous Medicine and Surgery
Melinda Gooderham, Mark G. Kirchhof, Irina Turchin, Marni Wiseman, Vipul Jain, Aaron Sihota   +5 more
openaire   +2 more sources